|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bertuccio P, Turati F, Carioli G,
Rodriguez T, La Vecchia C, Malvezzi M and Negri E: Global trends
and predictions in hepatocellular carcinoma mortality. J Hepatol.
67:302–309. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sharma SA, Kowgier M, Hansen BE, Brouwer
WP, Maan R, Wong D, Shah H, Khalili K, Yim C, Heathcote EJ, et al:
Toronto HCC risk index: A validated scoring system to predict
10-year risk of HCC in patients with cirrhosis. J Hepatol:
S0168-8278(17)32248-1. 2017.
|
|
5
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fu J and Wang H: Precision diagnosis and
treatment of liver cancer in China. Cancer Lett. 412:283–288. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carlucci A, Adornetto A, Scorziello A,
Viggiano D, Foca M, Cuomo O, Annunziato L, Gottesman M and
Feliciello A: Proteolysis of AKAP121 regulates mitochondrial
activity during cellular hypoxia and brain ischaemia. EMBO J.
27:1073–1084. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Czachor A, Failla A, Lockey R and
Kolliputi N: Pivotal role of AKAP121 in mitochondrial physiology.
Am J Physiol Cell Physiol. 310:C625–C628. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schiattarella GG, Cattaneo F, Pironti G,
Magliulo F, Carotenuto G, Pirozzi M, Polishchuk R, Borzacchiello D,
Paolillo R, Oliveti M, et al: Akap1 deficiency promotes
mitochondrial aberrations and exacerbates cardiac injury following
permanent coronary ligation via enhanced mitophagy and apoptosis.
PLoS One. 11:e01540762016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Smith FD, Langeberg LK and Scott JD: The
where's and when's of kinase anchoring. Trends Biochem Sci.
31:316–323. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cardone L, Carlucci A, Affaitati A,
Livigni A, DeCristofaro T, Garbi C, Varrone S, Ullrich A, Gottesman
ME, Avvedimento EV and Feliciello A: Mitochondrial AKAP121 binds
and targets protein tyrosine phosphatase D1, a novel positive
regulator of src signaling. Mol Cell Biol. 24:4613–4626. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rinaldi L, Sepe M, Delle Donne R, Conte K,
Arcella A, Borzacchiello D, Amente S, De Vita F, Porpora M, Garbi
C, et al: Mitochondrial AKAP1 supports mTOR pathway and tumor
growth. Cell Death Dis. 8:e28422017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bruix J and Sherman M: Practice Guidelines
Committee, American Association for the Study of Liver Diseases:
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Starley BQ, Calcagno CJ and Harrison SA:
Nonalcoholic fatty liver disease and hepatocellular carcinoma: A
weighty connection. Hepatology. 51:1820–1832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
El-Serag HB, Tran T and Everhart JE:
Diabetes increases the risk of chronic liver disease and
hepatocellular carcinoma. Gastroenterology. 126:460–468. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang JD, Mohamed HA, Cvinar JL, Gores GJ,
Roberts LR and Kim WR: Diabetes mellitus heightens the risk of
hepatocellular carcinoma except in patients with hepatitis C
cirrhosis. Am J Gastroenterol. 111:1573–1580. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Henze K and Martin W: Evolutionary
biology: Essence of mitochondria. Nature. 426:127–128. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weinberg SE and Chandel NS: Targeting
mitochondria metabolism for cancer therapy. Nat Chem Biol. 11:9–15.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vazquez F, Lim JH, Chim H, Bhalla K,
Girnun G, Pierce K, Clish CB, Granter SR, Widlund HR, Spiegelman BM
and Puigserver P: PGC1alpha expression defines a subset of human
melanoma tumors with increased mitochondrial capacity and
resistance to oxidative stress. Cancer Cell. 23:287–301. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Genini D, Brambilla L, Laurini E, Merulla
J, Civenni G, Pandit S, D'Antuono R, Perez L, Levy DE, Pricl S, et
al: Mitochondrial dysfunction induced by a SH2 domain-targeting
STAT3 inhibitor leads to metabolic synthetic lethality in cancer
cells. Proc Natl Acad Sci USA. 114:E4924–E4933. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yuan D, Huang S, Berger E, Liu L, Gross N,
Heinzmann F, Ringelhan M, Connor TO, Stadler M, Meister M, et al:
Kupffer cell-derived Tnf triggers cholangiocellular tumorigenesis
through JNK due to chronic mitochondrial dysfunction and ROS.
Cancer Cell. 31:771–789.e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Viale A, Pettazzoni P, Lyssiotis CA, Ying
H, Sánchez N, Marchesini M, Carugo A, Green T, Seth S, Giuliani V,
et al: Oncogene ablation-resistant pancreatic cancer cells depend
on mitochondrial function. Nature. 514:628–632. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bruix J, Reig M and Sherman M:
Evidence-based diagnosis, staging, and treatment of patients with
hepatocellular carcinoma. Gastroenterology. 150:835–853. 2016.
View Article : Google Scholar : PubMed/NCBI
|
